BackTable Cardiology is a podcast for clinical and interventional cardiologists, cardiac surgeons, and other healthcare professionals involved in cardiovascular care. This show brings together expert voices from across the field to explore the latest in cardiology—from evolving guidelines and innovative devices to real-world case discussions and multidisciplinary collaboration. BackTable Cardiology delivers practical insights and forward-thinking conversations to keep you connected and current in a rapidly changing specialty.
Site
RSS
Apple
Data updated on 14/07/2026
Recent rankings
Latest chart positions across Apple Podcasts and Spotify rankings.
Shared links between episodes and podcasts
Links found in episode descriptions and other podcasts that share them.
Ep. 26 Renal Denervation: Innovations in Hypertension Management with Dr. Eric Secemsky
Tuesday, February 24, 2026 • Duration 48:52
John Doe is a 45 year-old male with a past medical history of hypertension, on high doses of amlodipine, metoprolol and lisinopril presenting to his cardiologist with a blood pressure of 165/86. He asks, “If the medications are not controlling my blood pressure, what are my options?” In this episode of the BackTable Cardiology Podcast, Dr. Sameh Sayfo sits down with Dr. Eric Secemsky, an internationally recognized interventional cardiologist and vascular medicine specialist to discuss renal denervation, a minimally invasive procedure that lowers blood pressure by disrupting overactive renal sympathetic nerves.
---
SYNPOSIS
From its proof of concept to the clinical trials that have shaped the current landscape, Drs. Sayfo and Secemsky dive into the intricacies of renal denervation. They explore the technical aspects of catheter-based denervation devices like Medtronic's Spyral catheter and Recor's Paradise device, discussing their procedures, safety features, and troubleshooting tips. The conversation also covers the significance of building advanced hypertension centers, the latest in renal denervation innovations, and the creation of a national registry to track procedural outcomes and enhance patient care.
---
TIMESTAMPS
00:00 - Introduction02:52 - Guidelines Update: Why Renal Denervation Earned a Class 2B Recommendation07:31 - Clinical Trials: What Went Wrong, What We Learned, and How Devices Improved15:08 - Medtronic Symplicity Spyral22:17 - ReCor Paradise27:30 - Covering the Main Renal Artery: Anatomic Variants and Proximal Treatment Strategy33:15 - Beyond Kidneys: Multi-Organ Denervation and Metabolic Effects40:27 - Why Institutions Should Build Hypertension Centers
---
RESOURCES
Dr. Sameh Sayfo’s Provider Profilehttps://www.bswhealth.com/physician/sameh-sayf
Dr. Eric Secemsky’s Provider Profilehttps://findadoc.bidmc.org/details/3519
A Controlled Trial of Renal Denervation for Resistant Hypertensionhttps://www.nejm.org/doi/full/10.1056/NEJMoa1402670
Medtronic Symplicity Spyral™ Renal Denervation Systemhttps://www.medtronic.com/en-us/healthcare-professionals/products/surgical-energy/ablation/radiofrequency-ablation/systems/symplicity-spyral-renal-denervation-system.html
SPYRAL GEMINI Pilot Studyhttps://clinicaltrials.gov/study/NCT06907147
Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities (NECTAR IV) Trial https://clinicaltrials.gov/study/NCT05369065
Ep. 25 IVL & Atherectomy: Techniques for Complex PCI with Dr. Yousif Ahmad
Tuesday, February 17, 2026 • Duration 59:51
How do imaging, intravascular lithotripsy, and equipment selection come together to effectively target coronary calcium? In this episode of BackTable, interventional cardiologists Dr. Robert Riley (Overlake Medical Center in Bellevue, Washington) and Dr. Yousif Ahmad (UCSF) trade techniques and discuss various aspects of calcium modification in complex percutaneous coronary intervention (PCI).
---
This podcast is supported by:
Shockwave Medicalhttps://shockwavemedical.com/
---
SYNPOSIS
The discussion begins with an overview of intravascular lithotripsy (IVL), including its mechanism of action, ideal lesion characteristics, and performance across varying calcium morphologies. The conversation then expands to comparative decision-making among atherectomy, specialty balloons, and IVL, emphasizing how intravascular imaging informs procedural planning and real-time optimization. Key clinical data are reviewed, including the Disrupt CAD I-IV series as well as findings from the Short-Cut and VICTORY trials. The episode concludes with a forward-looking discussion on emerging technologies and the ongoing challenge of treating calcified nodules, one of the most demanding substrates in coronary intervention.
---
TIMESTAMPS
00:00 - Introduction04:16 - Complex PCI and Calcium Modification Tools04:43 - Intravascular Lithotripsy (IVL) Insights and Evolution12:08 - Calcium Modification Algorithms and Techniques27:24 - IVUS vs. OCT Imaging and Specialty Balloons32:12 - Challenges in Implementing New Techniques37:09 - Influential Studies in Calcium Modification40:52 - Recent Studies: Short-Cut and VICTORY53:11 - Future of Calcium Modification Technologies57:48 - Final Thoughts
---
RESOURCES
Dr. Robert Rileyhttps://www.scai.org/robert-f-riley-md-ms-fscai
Dr. Yousif Ahmadhttps://profiles.ucsf.edu/yousif.ahmad
Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysishttps://pubmed.ncbi.nlm.nih.gov/38401549/
Coronary intravascular lithotripsy for severe coronary artery calcification: The Disrupt CAD I-IV trialshttps://www.sciencedirect.com/science/article/abs/pii/S1553838924000769
Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation - ECLIPSEhttps://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2024/10/25/04/32/eclipse
Shockwave Lithoplasty Compared to Cutting Balloon Treatment in Calcified Coronary Disease - A Randomized Controlled Trial (Short-Cut)https://clinicaltrials.gov/study/NCT06089135
The Value of IVL Compared To OPN Non-Compliant Balloons for Treatment of RefractorY Coronary Lesions (VICTORY) Trial (VICTORY)https://clinicaltrials.gov/study/NCT05346068
Ep. 24 Mitigating Orthopedic Strain and Radiation Effects: Best Practices in the Cath Lab with Dr. Sahil Parikh
Tuesday, February 10, 2026 • Duration 50:12
This is a friendly reminder to unclench your jaw, sit up straight, and take a deep breath before diving into the latest episode of BackTable Cardiology! Host Dr. Sameh Sayfo from Baylor Scott & White Health speaks with Dr. Sahil Parikh, a renowned interventional cardiologist from Columbia University, about the health of interventional cardiologists. They discuss the various occupational hazards interventional cardiologists may be at risk for, particularly focusing on radiation exposure and orthopedic injuries caused by wearing lead aprons. The conversation touches on the need for better education and mandatory training for upcoming cardiologists to prevent such injuries.
---
SYNPOSIS
As Dr. Parikh shares his personal experiences with orthopedic issues related to the extensive use of lead protection, he highlights the importance of radiation safety and advocates for incorporating advanced protective technologies in the labs. Dr. Sayfo and Dr. Parikh also discuss the significant trials presented at TCT 2025, their potential impact on clinical practice, and the importance of advocacy by societies like SCAI and the American College of Cardiology (ACC) in improving interventional cardiologists' working conditions.
---
TIMESTAMPS
00:00 - Introduction01:58 - Orthopedic Issues in Interventional Cardiology04:00 - The Impact of Wearing Lead13:06 - Ergonomics and Risk Factors15:47 - Preventative Measures and Solutions23:22 - The Role of Medical Societies27:00 - Radiation Reduction Devices Overview30:57 - Barriers to Adopting Safety Technologies35:40 - Addressing Burnout in Interventional Cardiology42:06 - Highlights from TCT 2025
---
RESOURCES
Dr. Sahil Parikh Provider Profile https://doctors.columbia.edu/us/ny/new-york/sahil-a-parikh-md-161-fort-washington-avenue
Dr. Sameh Sayfo Provider Profile https://www.bswhealth.com/physician/sameh-sayfo
Cardiovascular Research Foundation's Transcatheter Cardiovascular Therapeutics (CRF TCT) Conference 2025 - The Global Forum for Interventional Cardiology https://www.tctconference.com/
Society for Cardiovascular Angiography & Interventionshttps://www.scai.org/
American College of Cardiologyhttps://www.acc.org/
Ep. 23 Understanding DEB in Coronary Interventions: Techniques & Outcomes with Dr. Mohammad Alkhalil and Dr. Abhishek Kumar
Tuesday, February 3, 2026 • Duration 43:56
Are drug-eluting balloons (DEBs) the best way to treat in-stent restenosis? In this episode of BackTable Cardiology, host and interventional cardiologist Dr. Sameh Sayfo takes a closer look at the evolving applications of coronary DEBs with two esteemed guests from the UK, Dr. Mohammad Alkhalil and Dr. Abhishek Kumar.
---
SYNPOSIS
This conversation covers the history and application of DEBs in treating in-stent restenosis (ISR) and small vessel disease, the differences between paclitaxel and limus-based drugs, the importance of lesion preparation and imaging, and the future potential of DEBs in coronary interventions. Dr. Kumar elaborates on the LOVE DEB study, which is investigating the use of DEBs in large de novo vessels, while Dr. Alkhalil shares his experiences and insights on adapting DEB technology in various clinical scenarios, including bifurcation lesions and acute myocardial infarction. The episode emphasizes the current role of DEB technology while cautioning against a reckless approach to its application.
---
TIMESTAMPS
00:00 - Introduction02:34 - Historical Perspective and Key Studies on DCB06:30 - Mechanisms and Imaging in In-Stent Restenosis11:39 - Comparing Paclitaxel and Limus DCBs13:24 - Choosing the Right DCB: Factors and Preferences17:23 - DCB in Complex Cases: Bifurcations and Beyond24:01 - Challenges and Adoption of DCB in Europe27:38 - The Role of Imaging in DCB Procedures30:13 - Insights from the LOVE DEB Study38:59 - Future Directions in DCB Technology
---
RESOURCES
Dr. Sameh Sayfo Provider Profile https://www.bswhealth.com/physician/sameh-sayfo
LOVE DEB Clinical Trialhttps://clinicaltrials.gov/study/NCT05915468
The European Bifurcation Club Left Main Coronary Stent Study: A Randomized Comparison of Stepwise Provisional vs. Systematic Dual Stenting Strategies (EBC MAIN)https://pubmed.ncbi.nlm.nih.gov/34002215/
Ep. 22 The Role of Cangrelor in Modern Interventional Cardiology: Practice, Guidelines, & Data Review with Dr. Roxana Mehran
Tuesday, January 27, 2026 • Duration 38:08
Fast acting and reversible: IV cangrelor offers rapid on, rapid off P2Y12 platelet inhibition that sidesteps oral absorption delays. In this episode of the BackTable Cardiology Podcast, host Dr. Sameh Sayfo welcomes renowned interventional cardiologist Dr. Roxana Mehran, incoming President elect of the American College of Cardiology (ACC), to discuss the emerging role of cangrelor and its implications on current cardiology practice.
---
This podcast is supported by an educational grant from Cheisi.
---
SYNPOSIS
Dr. Mehran and Dr. Sayfo cover the history and outcomes of the CHAMPION PHOENIX trial, cangrelor’s adoption and underutilization, and the nuances of transitioning high acuity patients between IV and PO antiplatelet therapies. Dr. Mehran also addresses the role of gender in cardiovascular health and the importance of inclusive representation in clinical studies. The episode concludes with Dr. Mehran sharing her initiatives to support women and minorities in cardiology, including her work as co-founder of Women As One.
---
TIMESTAMPS
00:00 - Introduction to the BackTable Podcast01:57 - Understanding Cangrelor and Its Impact02:18 - CHAMPION PHOENIX Study Insights07:02 - Challenges and Misconceptions of Cangrelor in Cardiogenic Shock and STEMI14:41 - Antiplatelet Bridging to Surgery and Gender Differences in Treatment17:39 - The SMILE Study and Real-World Applications20:49 - Advancing Women in Cardiology29:22 - Future of Interventional Cardiology32:53 - Holistic Cardiac and Vascular Health36:01 - Conclusion and Final Thoughts
---
RESOURCES
Dr. Roxana Mehran:https://profiles.mountsinai.org/roxana-mehran
Dr. Sameh Sayfo:https://www.bswhealth.com/physician/sameh-sayfo
Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events (CHAMPION PHOENIX Trial):https://www.nejm.org/doi/full/10.1056/NEJMoa1300815
Cangrelor versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition – CHAMPION Platform Clinical Trialhttps://www.clinicaltrials.gov/study/NCT00385138
Intravenous Platelet Blockade with Cangrelor during PCI (CHAMPION PCI):https://www.nejm.org/doi/full/10.1056/NEJMoa0908629
Meta-Analysis of the Role of Cangrelor for Patients Undergoing Percutaneous Coronary Interventionhttps://www.sciencedirect.com/science/article/abs/pii/S0002914919300426
Timing, indications and transition patterns associated with cangrelor use in patients undergoing PCIhttps://pubmed.ncbi.nlm.nih.gov/40813532/
Women As Onehttps://womenasone.org/about/
Ep. 21 Current HFpEF Treatments: Clinical Pearls & Progress with Dr. Jessica Huston
Tuesday, January 20, 2026 • Duration 54:28
If your New Year’s resolution involves learning more about current practice guidelines and emerging research on Heart Failure with Preserved Ejection Fraction (HFpEF), you’re in the right place! In this episode of the BackTable Cardiology Podcast, host Dr. Hady Lichaa welcomes heart failure specialist Dr. Jessica Huston to provide a practical update on managing heart failure with preserved ejection fraction (HFpEF).
---
SYNPOSIS
Dr. Huston and Dr. Lichaa discuss the complexity of diagnosing HFpEF, differences between HFpEF and diastolic heart failure, phenotypes within HFpEF, and treatment strategies, including the use of aldosterone blockers, SGLT-2 inhibitors, and GLP-1 agonists. Dr. Huston emphasizes the importance of phenotyping patients for accurate diagnosis and treatment, and discusses the potential of future therapies and devices. Their conversation also covers the role of inflammation, metabolic syndrome, and the challenges faced in managing fluid balance and hypertension in HFpEF patients.
---
TIMESTAMPS
00:00 - Introduction02:20 - Understanding HFpEF05:23 - Phenotypes and Treatment Approaches06:29 - Metabolic Syndrome and HFpEF09:17 - Emerging Treatments and Clinical Trials11:36 - Medication Strategies and Challenges24:51 - Diuretics and Their Limitations31:35 - Advanced Diuretic Strategies35:37 - Hemodynamic Measurements and Their Implications40:02 - Coronary Disease and HFpEF42:52 - Future Directions in Heart Failure Treatment45:45 - Device Therapies and Patient Management49:39 - Concluding Thoughts and Future Prospects
---
RESOURCES
Dr. Jessica Huston Provider Profilehttps://healthcare.ascension.org/find-care/provider/1073874616/jessica-huston
Dr. Hady Lichaa Provider Profilehttps://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa
The SUMMIT Trialhttps://pubmed.ncbi.nlm.nih.gov/39555826/
The TOPCAT Trialhttps://pubmed.ncbi.nlm.nih.gov/24716680/
The FINEARTS Trialhttps://pubmed.ncbi.nlm.nih.gov/39225278/
The CADENCE Trialhttps://www.clinicaltrials.gov/study/NCT04945460
Ep. 20 System Innovations in Medical Practice with Dr. Mohamad Alkhouli
Tuesday, January 13, 2026 • Duration 33:49
Clinicians play a central role in shaping cardiovascular innovation, yet many lack a clear pathway to participate. In this episode of BackTable Cardiology, Dr. Sameh Sayfo speaks with Dr. Mohamad Alkhouli, cardiologist and Chair of Research and Innovation at the Mayo Clinic, about practical approaches for clinician involvement in healthcare innovation and strategies to address persistent gaps in cardiovascular care access.
---
SYNPOSIS
The discussion examines Dr. Alkhouli’s decision to pursue an MBA, the role of business and organizational training in medical leadership, and how system-level thinking informs innovation beyond device development. Broader themes include stakeholder alignment, organizational behavior, and emerging opportunities for non-device innovation within contemporary cardiovascular practice.
---
TIMESTAMPS
00:00 - Introduction01:49 - The Value of an MBA for Physicians05:24 - Understanding Systems and Organizational Behavior07:31 - Navigating Innovation in MedTech13:15 - Bridging the Gap Between Physicians and Business19:44 - The Role of Professional Societies in Innovation25:32 - Future Trends in Interventional Cardiology29:58 - Global Perspectives on Innovation31:47 - Closing Remarks and Credits
---
RESOURCES
American College of Cardiologyhttps://www.acc.org/
Bolt Medical AcquisitionBoston Scientific Announces Agreement to Acquire Bolt Medical, Inc.
Silk Road Medical AcquisitionBoston Scientific Closes Acquisition of Silk Road Medical, Inc.
Dr. Mohamad Alkhouli’s Provider Profile https://www.mayoclinic.org/biographies/alkhouli-mohamad-m-d-m-b-a/bio-20465257
Dr. Sameh Sayfo’s Provider Profilehttps://www.bswhealth.com/physician/sameh-sayfo
Ep. 19 Intravenous Antiplatelet Therapy in Acute Coronary Syndrome with Dr. Hayder Hashim
Tuesday, January 6, 2026 • Duration 52:20
Preventing problems before they aggregate, P2Y12 inhibitor style! In this episode of the BackTable Cardiology Podcast, interventional cardiologist from MedStar Washington Hospital Center joins host Dr. Hady Lichaa for practical insights and key takeaways on antiplatelet use in the setting of acute coronary syndrome (ACS).---This podcast is supported by an educational grant from Cheisi.---SYNPOSISDr. Hashim talks through the use of intravenous antiplatelet therapies, specifically cangrelor, for managing acute coronary syndrome. Their discussion explores the pharmacokinetics, clinical advantages, and potential future applications of IV P2Y12 inhibitors. Dr. Hashim shares his wealth of experience in antiplatelet case studies and shares best practices when transitioning patients from IV to oral antiplatelet therapies. The conversation focuses on enhancing patient outcomes, minimizing complications, and lessons learned from different clinical scenarios.---TIMESTAMPS00:00 - Introduction03:31 - Intravenous Antiplatelet Therapies Overview06:01 - The Importance of IV P2Y12 Inhibitors09:15 - Guidelines and Usage of GP IIb/IIIa Inhibitors11:30 - Advantages of IV P2Y12 Inhibitors in Clinical Practice14:32 - Practical Applications and Case Studies24:42 - Cost Effectiveness, Hospital Administration, Financial Implications28:20 - Contraindications and Practical Considerations30:09 - Loading and Infusion Protocols34:58 - Bridging for Surgery39:48 - Anticoagulation and Heparin Goals48:55 - Future of IV Antiplatelet Therapy50:44 - Conclusion---RESOURCESAssociation of 2B3A inhibition with new antiplatelet regimens in the setting of acute coronary syndromes: a meta-analysis of randomized controlled trialshttps://academic.oup.com/eurheartj/article-abstract/34/suppl_1/P4861/2862796 Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events - CHAMPION PHOENIXhttps://www.nejm.org/doi/full/10.1056/NEJMoa1300815 Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trialhttps://pubmed.ncbi.nlm.nih.gov/38237620/ Abstract 4370674: Cangrelor Versus Oral P2Y12 Inhibitors During PCI in Cardiogenic Shock and Cardiac Arrest: A Systematic Review and Meta-analysishttps://www.ahajournals.org/doi/10.1161/circ.152.suppl_3.4370674Dr. Hayder Hashimhttps://www.medstarhealth.org/doctors/hayder-hashim-md Dr. Hady Lichaahttps://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa
Ep. 18 The Role of Minimally Invasive Robotic Cardiac Surgery in Modern Cardiology Practice with Dr. Amber Edwards
Tuesday, December 30, 2025 • Duration 52:26
From sternotomy to software, the booming field of robotic cardiac surgery is bringing new minimally invasive treatment approaches to well-traveled cardiology conditions. This week on the BackTable Cardiology Podcast, Dr. Amber Edwards, a distinguished cardiothoracic surgeon from Ascension St. Thomas in Nashville, shares her expertise in robotic cardiac surgery with host and Tennessee neighbor Dr. Hady Lichaa. The two physicians discuss the growth and technical advancements within robotic cardiac surgery, including the burgeoning field of hybrid revascularization.
---
SYNPOSIS
Dr. Edwards outlines her journey in the cardiothoracic field, sharing her experiences with pioneers of minimally invasive and robotic cardiac surgeries. The discussion explores various procedures, including totally endoscopic coronary artery bypass (TECAB), minimally invasive direct coronary artery bypass (MIDCAB), and robotic LIMA to LAD bypass. Dr. Edwards also elaborates on robotic left atrial appendage ligations, robotic mitral and aortic valve surgeries, and conversion procedures for atrial fibrillation, highlighting their technical challenges, patient selection, and potential for broader adoption.
---
TIMESTAMPS
00:00 - Introduction03:33 - MIDCAB and TECAB Procedures07:11 - Preoperative Testing and Considerations09:09 - Challenges and Complexities in Robotic Surgery17:20 - Hybrid Revascularization and Antiplatelet Therapy26:02 - The Future and Adoption of Robotic Surgery30:56 - Exploring Robotic Left Atrial Appendage Ligation32:03 - The Convergent Procedure for AFib Patients40:56 - Robotic Mitral Valve Surgery: Techniques and Benefits47:11 - The Future of Robotic Cardiac Surgery50:20 - Conclusion
---
RESOURCES
Dr. Amber Edwardshttps://healthcare.ascension.org/find-care/provider/1699031591/amber-edwards
Dr. Hady Lichaahttps://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women (RECHARGE:W)https://clinicaltrials.gov/study/NCT06399692
Ep. 17 Update in Intravascular Imaging for Optimal PCI with Dr. Erik Rafflenbeul
Tuesday, December 16, 2025 • Duration 55:02
Intravascular imaging can provide invaluable intel on the coronaries, with OCT supplying bright ideas and IVUS giving sound judgement. Light-based and soundwave-based, respectively, mastery of these two imaging modalities can help you streamline routine PCI cases and overcome challenging ones. In this episode of BackTable Cardiology, the esteemed Dr. Erik Rafflenbeul from Schön Klinik in Hamburg, Germany joins host Dr. Hady Lichaa from Tennessee’s Ascension St. Thomas Heart to discuss intravascular imaging techniques for percutaneous coronary interventions.
---
SYNPOSIS
The conversation covers a wide range of topics, including the importance and benefits of using intravascular imaging, the differences and applications of intravascular ultrasound (IVUS) and optical coherence tomography (OCT) systems, recent intravascular clinical studies to know, and practical aspects of integrating these technologies into daily practice. Dr. Rafflenbeul emphasizes the value of proactive imaging and shares comprehensive insights for both seasoned and early-career interventional cardiologists.
---
TIMESTAMPS
00:00 - Introduction03:52 - Current State of Intravascular Imaging in Germany and Europe05:26 - Importance of Intravascular Imaging in PCI09:08 - Challenges and Adoption of Intravascular Imaging13:30 - IVUS vs. OCT: Which to Choose?17:06 - Practical Insights on IVUS and OCT Systems28:50 - Pre-Procedural Measurements and Techniques30:36 - Choosing Stent Diameters32:22 - Practical Aspects of Stenting36:40 - Post-PCI Assessment and Algorithm40:35 - Recent Intravascular Imaging Studies43:07 - Case Studies and Practical Tips47:16 - Advice for Early Career Interventionalists 51:54 - Concluding Thoughts and Wisdom
---
RESOURCES
Dr. Hady Lichaahttps://healthcare.ascension.org/find-care/provider/1336267533/hady-lichaa
Dr. Erik Rafflenbeulhttps://www.pcronline.com/Physicians/Erik-Rafflenbeul
European Association of Percutaneous Cardiovascular Interventions (EAPCI)https://www.escardio.org/Sub-specialty-communities/European-Association-of-Percutaneous-Cardiovascular-Interventions-%28EAPCI%29#
Optimal Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Patients With Multivessel Diseasehttps://www.jacc.org/doi/10.1016/j.jacasi.2022.12.009#:~:text=The%20OPTIVUS%20(Optimal%20IntraVascular%20Ultrasound)%2DComplex%20PCI%20study,infarction%20*%20Stroke%20*%20Any%20coronary%20revascularization
Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysishttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02454-6/abstract
Orbital Atherectomy vs. Conventional Balloon Angioplasty in Severely Calcified Coronary Arteries Prior to DES Implantation - ECLIPSEhttps://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2024/10/25/04/32/eclipse
A Revised Optical Coherence Tomography–Derived Calcium Score to Predict Stent Underexpansion in Severely Calcified Lesionshttps://www.sciencedirect.com/science/article/abs/pii/S193687982401817X#:~:text=Lesions%20with%20severe%20calcium%20as,higher%20risk%20for%20stent%20underexpansion.
Intravascular Imaging vs Angiography Guidance for PCI of Severely Calcified Lesions: The ECLIPSE Trialhttps://pubmed.ncbi.nlm.nih.gov/41093451/#:~:text=The%20primary%20clinical%20outcome%20was,tomographic%20guidance%20and%20IVUS%20guidance.
Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents - ADAPT-DEShttps://www.acc.org/latest-in-cardiology/clinical-trials/2012/10/25/11/12/adapt-des
Related Shows Based on Content Similarities
Discover shows related to Backtable Cardiology, based on actual content similarities. Explore podcasts with similar topics, themes, and formats, backed by real data.
